Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Carparts.Com Inc (PRTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Carparts.Com Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Carparts.Com Inc trades at $7.75 (market cap $63.04M). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 140.9× Carparts.Com Inc's market cap, and Carparts.Com Inc is more actively traded (22,319 versus 1,028,790). Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Carparts.Com Inc for 45 Days on average.
| KYMR | PRTS | |
|---|---|---|
Market Cap | $8.88B | $63.04M |
Volume | 1,028,790 | 22,319 |
Sector | Health | Consumer Cyclical |
52-Week High | $127.31 | $10.00 |
52-Week Low | $55.80 | $3.88 |
Typical Hold Time | 0 Days | 45 Days |
Enterprise Value | $8.27B | $76.01M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CarParts.com (PRTS) trades at $8.11, down 6.46% today, reflecting ongoing volatility amid mixed financials. The company has beaten EPS estimates for three consecutive quarters, yet revenue has declined from $676M in 2023 to $548M in 2025, with net losses widening to -$50M. Analyst sentiment is positive with 60% buy ratings, but negative cash flow from operations and weak profitability metrics highlight operational challenges.
The outlook remains cautious; while low P/S of 0.11 suggests undervaluation, persistent losses and declining revenue pose significant risks. Near-term catalysts depend on reversing negative cash flow and achieving profitability. Investors face upside from execution improvements but downside from competitive pressures and macroeconomic headwinds affecting consumer discretionary spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Carparts.Com Inc
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Read more on PRTS →
